SUPERBRANCHE is a biotechnology company for the early detection and treatment of metastases through nanotechnological provisions.
SUPERBRANCHE has raised $13.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
SUPERBRANCHE's investors include Bpifrance, Capital Grand Est.
SUPERBRANCHE is headquartered in Strasbourg, France.
SUPERBRANCHE is a biotechnology company for the early detection and treatment of metastases through nanotechnological provisions.
SUPERBRANCHE is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SUPERBRANCHE — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/superbranche. Accessed August 14, 2026.
VCBacked. (2025). SUPERBRANCHE — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/superbranche
{{cite web |title=SUPERBRANCHE — Funding & Investors |url=https://www.vcbacked.co/company/superbranche |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated